Hyundai Mobis to offer better collision warningHyundai Mobis has developed a high-tech forward collision avoidance system to be used in commercial vehicles starting in 2021.
The largest auto parts maker in Korea, affiliated with Hyundai Motor and Kia Motors, announced in a statement Sunday that it has developed a driver state warning (DSW) system and would start installing it in middle and large-sized commercial vehicles in the future.
Unlike the warning systems currently used in some luxury vehicles that only detect head and eyelid movements of a driver, the new technology can also detect the identity of a driver and his or her pupil movements. The DSW system combines analysis from infrared cameras and driving information related to vehicle acceleration, gear shift and handling.
The system warns drivers of their lack of attention or drowsy driving and thereby prevents collisions.
The system, for which up to 10 drivers can register as users, will be initially added to Hyundai Motor-made trucks and vans and later to buses and passenger vehicles.
Hyundai Mobis said it has decided to deploy the system in trucks and vans first, as one out of four traffic accidents involve commercial vehicles, according to data from Korea Transportation Safety Authority compiled between 2012 and 2017. The auto parts maker expects the new high-tech system to reduce the number of accidents, as careless driving causes 42 percent of all road accidents.
According to Yano Research Institute, the global market for driver-monitoring systems is expected to grow 12.2 percent on average annually, from 240 billion won ($204 million) in 2015 to 680 billion won by 2025.
Hyundai Mobis earlier announced that it plans to test and roll out 100 self-driving taxi vehicles in Russia by the end of this year.
BY KO JUN-TAE [email@example.com]
More in Industry
Luxury loungewear is no longer just for lounging
KGC to work on a ginseng-based vaccine adjuvant
Hanwha Techwin continues selling CCTV systems overseas
Popeyes to close all branches in Korea this month
Contract signed for Covid-19 vaccine